The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPredator Oil Regulatory News (PRD)

Share Price Information for Predator Oil (PRD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.90
Bid: 9.50
Ask: 11.00
Change: 0.00 (0.00%)
Spread: 1.50 (15.789%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 9.90
PRD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of Warrants

12 Jul 2022 07:00

RNS Number : 0875S
Predator Oil & Gas Holdings PLC
12 July 2022
 

 

FOR IMMEDIATE RELEASE

12 July 2022

 

Predator Oil & Gas Holdings Plc / Index: LSE / Epic: PRD / Sector: Oil & Gas

LEI 213800L7QXFURBFLDS54

Predator Oil & Gas Holdings Plc

("Predator" or the "Company" and together with its subsidiaries "the Group")

 

Exercise of Warrants

Predator Oil & Gas Holdings Plc (PRD), the Jersey-based Oil and Gas Company with operations in Trinidad, Morocco and Ireland announces that it has received an exercise notice from Novum Securities Limited ("Novum") in respect of warrants issued to it pursuant to warrant agreements with the Company:

dated 24 May 2018 (in connection with the Placing carried out by the Company in May 2018 on admission of the Company to the Official List (standard listing segment) of the London Stock Exchange's main market for listed securities) to subscribe for 1,892,960 new shares of no par value each in the Company ("New Ordinary Shares") at 2.8p per share, and

dated 17 February 2020 (in connection with the Placing carried out by the Company in February 2020) to subscribe for 2,256,250 new shares of no par value each in the Company ("New Ordinary Shares") at 4p per share.

The Company has therefore allotted and issued the total of 4,149,210 New Ordinary Shares following receipt of the aggregate £143,252.88 subscription price from Novum. Application will be made to the Financial Conduct Authority ("FCA") for the New Ordinary Shares to be admitted to listing on the Official List (standard listing segment) of the FCA and to the London Stock Exchange for the New Ordinary Shares to be admitted to trading on the London Stock Exchange's main market for listed securities (together "Admission").

The Company advises that, following this Admission, the Company's issued share capital will be 308,595,477 shares of no par value, each with one vote per share (and no such shares are held in treasury). The total number of voting rights is therefore 308,595,477.

The above figure of 308,595,477 may be used by shareholders as the denominator for the calculations to determine if they have a notifiable interest in the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules, or if such interest has changed. 

 

Directors' Holdings

The positions held by the Directors are as follows:

 

DIRECTOR

TOTAL SHARES

OPTIONS

18 May 2018

OPTIONS

27 October 2020

OPTIONS

31 January 2022

OPTIONS

5 July 2022

Paul Griffiths

46,871,508

4,005,486

3,850,000

Nil

Nil

Stephen Staley

669,600

1,001,370

1,650,000

Nil

Nil

Louis Castro

Nil

Nil

1,650,000

1,000,000

Nil

Lonny

Baumgardner

555,600

Nil

Nil

7,855,486

Nil

Alistar Jury

Nil

Nil

Nil

Nil

2,000,000

Tom Evans

Nil

Nil

Nil

Nil

2,000,000

 

Details of the 2018 and 2020 option awards may be found in the Company's annual report.

Options issued on 5 July 2022 are exercisable at 8.125 pence per share, being the closing mid-market price on 4 July 2022, and will vest after 6 months.

 

Total Options and Warrants on issue

Following the exercise of the warrants by Novum, the total options and warrants outstanding in the Company are as follows:

 

OPTIONS

18 May 2018¹

OPTIONS

27 October 2020²

WARRANTS³

OPTIONS 

31 January 20224

OPTIONS 

5 July 2022⁵

Directors 

5,006,856

7,150,000

Nil

8,855,486

4,000,000

Previous director

1,001,370

Nil

Nil

Nil

Advisers

and others

Nil

Nil

5,974,468

Nil

(1) 18/5/18 options are exercisable at 2.8 pence per share

(2) 27/10/20 options are exercisable at 5 pence per share

(3) Warrants include outstanding warrants issued to Company advisers at

an exercise price of 2.8 pence per share (160,718 on 24 May 2018), 12 pence per share (2,000,000 on 15 February 2019), 4 pence per share (2,193,750 on 17 February 2020), 10.5 pence per share (1,020,000 on 12 March 2021), 15 pence per share (600,000 on 18 June 2021) and 9 pence per share (690,000 on 28 March 2022). Further details of the 2018, 2019, 2020 and 2021 warrant awards may be found in the Company's 2021 Annual Report and Financial Statements.

(4) 8,855,486 options are exercisable at 5.66 pence per share.

(5) 4,000,000 options are exercisable at 8.125 pence per share.

 

If all options and warrants were to become exercisable and then exercised in accordance with their terms, gross proceeds received by the Company would be £1,881,301.

 

 

This announcement contains inside information for the purposes of Article 7 of the Regulation (EU) No 596/2014 on market abuse

For more information please visit the Company's website at www.predatoroilandgas.com

 

 

 

Enquiries:

Predator Oil & Gas Holdings Plc

Paul Griffiths Executive Chairman

Lonny Baumgardner Managing Director

Tel: +44 (0) 1534 834 600

Info@predatoroilandgas.com

Novum Securities Limited

Jon Belliss

 

Optiva Securities Limited

Christian Dennis

 

Peterhouse Capital Limited

Charles Goodfellow

Tel: +44 (0) 207 399 9425

 

 

Tel: +44 (0) 203 137 1902

 

 

Tel: +44 (0) 207 220 9791

Flagstaff Strategic and Investor Communications

Tim Thompson 

Mark Edwards

Fergus Mellon

Tel: +44 (0) 207 129 1474

predator@flagstaffcomms.com

 

Notes to Editors:

 

Predator is operator of the Guercif Petroleum Agreement onshore Morocco which is prospective for Tertiary gas in prospects less than 10 kilometres from the Maghreb gas pipeline. The MOU-1 well has been completed and a follow-up testing programme is being developed and a further drilling programme is under review.

 

Predator is seeking to further develop the remaining oil reserves of Trinidad's mature onshore oil fields through the application of CO2 EOR techniques and by sequestrating anthropogenic carbon dioxide to produce "greener" oil.

 

In addition, Predator also owns and operates exploration and appraisal assets in licensing options offshore Ireland, for which successor authorisations have been applied for, adjoining Vermilion's Corrib gas field in the Slyne Basin on the Atlantic Margin and east of the decommissioned Kinsale gas field in the Celtic Sea.

 

Predator has developed a Floating Storage and Regasification Project ("FSRUP") for the import of LNG and its regassification for Ireland and is also developing gas storage concepts to address security of gas supply and volatility in gas prices during times of peak gas demand.

 

The Company has a highly experienced management team with a proven track record in operations in the oil and gas industry.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGPUMAMUPPGMG
Date   Source Headline
9th May 20079:15 amRNSMonthly Commentary
9th May 20077:03 amRNSDividend Declaration
9th May 20077:00 amRNS1st Quarter Results
3rd May 20072:00 pmRNSAnnual Report and Accounts
2nd May 20071:24 pmRNSHolding(s) in Company
1st May 20073:47 pmRNSNet Asset Value(s)
30th Apr 20075:46 pmRNSNotice of AGM
27th Apr 200711:47 amRNSHolding(s) in Company
25th Apr 20073:05 pmRNSHolding(s) in Company
25th Apr 20073:02 pmRNSHolding(s) in Company
23rd Apr 200710:30 amRNSHolding(s) in Company
20th Apr 20079:19 amRNSNotice of Results
10th Apr 200710:15 amRNSMonthly Commentary
3rd Apr 20075:04 pmRNSPortfolio Update
2nd Apr 20076:13 pmRNSNet Asset Value(s)
2nd Apr 20072:53 pmRNSHolding(s) in Company
30th Mar 20074:53 pmRNSDirector/PDMR Shareholding
30th Mar 20074:48 pmRNSTotal Voting Rights
27th Mar 20073:02 pmRNSFurther re Issue of Equity
27th Mar 20077:04 amRNSIssue of Equity
21st Mar 20074:40 pmRNSHolding(s) in Company
21st Mar 20074:19 pmRNSHolding(s) in Company
16th Mar 20073:04 pmRNSDirector Declaration
16th Mar 200711:41 amRNSHolding(s) in Company
12th Mar 200711:00 amRNSMonthly Commentary
8th Mar 20077:02 amRNSPreliminary Results
1st Mar 20072:55 pmRNSNet Asset Value(s)
28th Feb 20075:21 pmRNSDividend Conversion rate
13th Feb 20077:02 amRNSDividend Declaration
13th Feb 20077:01 amRNSPreliminary Results
12th Feb 20072:49 pmRNSHolding(s) in Company
9th Feb 200712:38 pmRNSMonthly Commentary - Replace
9th Feb 200712:16 pmRNSMonthly Commentary
8th Feb 200712:12 pmRNSHolding(s) in Company
1st Feb 20072:36 pmRNSNet Asset Value(s)
10th Jan 200711:00 amRNSMonthly Commentary
10th Jan 20079:04 amRNSHolding(s) in Company
9th Jan 200710:00 amRNSNotice of Results
5th Jan 20079:37 amRNS2007-8 Financial Calendar
3rd Jan 20074:27 pmRNSPortfolio Update
3rd Jan 20079:18 amRNSNet Asset Value(s)
21st Dec 20063:28 pmRNSTotal Voting Rights
21st Dec 20063:23 pmRNSHolding(s) in Company
14th Dec 20065:18 pmRNSHolding(s) in Company
11th Dec 200612:01 pmRNSMonthly Commentary
1st Dec 20063:24 pmRNSHolding(s) in Company
1st Dec 20069:37 amRNSNet Asset Value(s)
30th Nov 20062:44 pmRNSDirector Declaration
28th Nov 20065:00 pmRNSHolding(s) in Company
8th Nov 20069:18 amRNSMonthly Commentary

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.